MXPA03004652A - Derivados de piperidina como antagonistas selectivos de subtipo de n-metil-d-aspartato. - Google Patents
Derivados de piperidina como antagonistas selectivos de subtipo de n-metil-d-aspartato.Info
- Publication number
- MXPA03004652A MXPA03004652A MXPA03004652A MXPA03004652A MXPA03004652A MX PA03004652 A MXPA03004652 A MX PA03004652A MX PA03004652 A MXPA03004652 A MX PA03004652A MX PA03004652 A MXPA03004652 A MX PA03004652A MX PA03004652 A MXPA03004652 A MX PA03004652A
- Authority
- MX
- Mexico
- Prior art keywords
- methyl
- piperidine derivatives
- subtype selective
- aspartate antagonists
- aspartate
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25783200P | 2000-12-21 | 2000-12-21 | |
PCT/IB2001/002277 WO2002050070A2 (en) | 2000-12-21 | 2001-11-30 | Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA03004652A true MXPA03004652A (es) | 2003-09-05 |
Family
ID=22977943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA03004652A MXPA03004652A (es) | 2000-12-21 | 2001-11-30 | Derivados de piperidina como antagonistas selectivos de subtipo de n-metil-d-aspartato. |
Country Status (13)
Country | Link |
---|---|
US (1) | US6642256B2 (es) |
EP (1) | EP1345935A2 (es) |
JP (1) | JP2004516295A (es) |
AU (1) | AU2002223968A1 (es) |
BR (1) | BR0116311A (es) |
CA (1) | CA2436699A1 (es) |
HN (1) | HN2001000280A (es) |
MX (1) | MXPA03004652A (es) |
PA (1) | PA8535901A1 (es) |
PE (1) | PE20020882A1 (es) |
TN (1) | TNSN01175A1 (es) |
UY (1) | UY27081A1 (es) |
WO (1) | WO2002050070A2 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19952147A1 (de) * | 1999-10-29 | 2001-05-03 | Boehringer Ingelheim Pharma | Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
TW200303304A (en) | 2002-02-18 | 2003-09-01 | Astrazeneca Ab | Chemical compounds |
US7273889B2 (en) * | 2002-09-25 | 2007-09-25 | Innovative Drug Delivery Systems, Inc. | NMDA receptor antagonist formulation with reduced neurotoxicity |
JP2007504123A (ja) | 2003-08-29 | 2007-03-01 | ランバクシー ラボラトリーズ リミテッド | Iv型ホスホジエステラーゼの阻害剤 |
SE0400208D0 (sv) | 2004-02-02 | 2004-02-02 | Astrazeneca Ab | Chemical compounds |
GT200600042A (es) * | 2005-02-10 | 2006-09-27 | Aventis Pharma Inc | Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a |
JPWO2006137465A1 (ja) * | 2005-06-24 | 2009-01-22 | 塩野義製薬株式会社 | 含窒素複素環誘導体 |
US7781460B2 (en) | 2005-09-05 | 2010-08-24 | Ranbaxy Laboratories Limited | Substituted indazoles as inhibitors of phosphodiesterase type-IV |
EP1934219A1 (en) | 2005-09-16 | 2008-06-25 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
PT2124944E (pt) | 2007-03-14 | 2012-05-17 | Ranbaxy Lab Ltd | Derivados de pirazolo[3,4-b]piridina como inibidores de fosfodiesterase |
JP5573307B2 (ja) * | 2010-03-31 | 2014-08-20 | Jsr株式会社 | 感放射線性樹脂組成物、重合体及び化合物 |
CA2802295C (en) | 2010-06-11 | 2016-09-20 | Rhodes Technologies | Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof |
EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
EP2592077A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
CN110662541B (zh) * | 2017-03-12 | 2023-02-10 | 王晓冬 | 多环胺作为阿片受体调节剂 |
KR101798840B1 (ko) | 2017-05-17 | 2017-11-17 | 주식회사 레고켐 바이오사이언스 | 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9509760A (pt) | 1994-11-23 | 1998-06-30 | Neurogen Corp | Composto |
DE19531321A1 (de) | 1995-08-25 | 1997-02-27 | Merck Patent Gmbh | Piperidinylmethyloxazolidinone |
ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
ZA9610745B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
ZA9610736B (en) | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
DE19739332C1 (de) | 1997-09-09 | 1998-11-26 | Merck Patent Gmbh | Piperidinylmethyloxazolidinon-Derivat |
US6015824A (en) | 1998-02-10 | 2000-01-18 | Hoffmann-La Roche Ag | Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders |
DE19812331A1 (de) | 1998-03-20 | 1999-09-23 | Merck Patent Gmbh | Piperidinderivate |
WO1999050264A1 (fr) | 1998-03-30 | 1999-10-07 | Kyowa Hakko Kogyo Co., Ltd. | Derives de quinazoline |
WO2000018763A2 (en) | 1998-09-29 | 2000-04-06 | Neurogen Corporation | 2-(2,3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands |
-
2001
- 2001-11-30 MX MXPA03004652A patent/MXPA03004652A/es not_active Application Discontinuation
- 2001-11-30 CA CA002436699A patent/CA2436699A1/en not_active Abandoned
- 2001-11-30 JP JP2002551566A patent/JP2004516295A/ja not_active Abandoned
- 2001-11-30 WO PCT/IB2001/002277 patent/WO2002050070A2/en not_active Application Discontinuation
- 2001-11-30 EP EP01271104A patent/EP1345935A2/en not_active Withdrawn
- 2001-11-30 BR BR0116311-6A patent/BR0116311A/pt not_active IP Right Cessation
- 2001-11-30 AU AU2002223968A patent/AU2002223968A1/en not_active Abandoned
- 2001-11-30 US US09/998,479 patent/US6642256B2/en not_active Expired - Fee Related
- 2001-12-18 PE PE2001001265A patent/PE20020882A1/es not_active Application Discontinuation
- 2001-12-18 UY UY27081A patent/UY27081A1/es not_active Application Discontinuation
- 2001-12-19 HN HN2001000280A patent/HN2001000280A/es unknown
- 2001-12-20 TN TNTNSN01175A patent/TNSN01175A1/fr unknown
- 2001-12-21 PA PA20018535901A patent/PA8535901A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2002223968A1 (en) | 2002-07-01 |
HN2001000280A (es) | 2002-01-30 |
JP2004516295A (ja) | 2004-06-03 |
CA2436699A1 (en) | 2002-06-27 |
US20030018021A1 (en) | 2003-01-23 |
WO2002050070A3 (en) | 2002-09-19 |
WO2002050070A2 (en) | 2002-06-27 |
EP1345935A2 (en) | 2003-09-24 |
US6642256B2 (en) | 2003-11-04 |
PA8535901A1 (es) | 2002-08-29 |
TNSN01175A1 (fr) | 2005-11-10 |
UY27081A1 (es) | 2002-07-31 |
PE20020882A1 (es) | 2002-09-28 |
BR0116311A (pt) | 2003-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03001143A (es) | Derivados de 4-fenil-piridina como antagonistas del receptor de neuroquinina-1. | |
ZA200204395B (en) | Selective neurokinin antagonists. | |
ZA200108867B (en) | Piperidine derivatives useful as CCR5 antagonists. | |
ZA200108868B (en) | Piperazine derivatives useful as CCR5 antagonists. | |
IL153224A0 (en) | 1,4-dihydropyridines as bradykinin antagonists | |
IL152209A0 (en) | Benzoamide piperidine compounds as substance p antagonists | |
HK1046909A1 (en) | Piperazine derivatives as 5-ht1b antagonists. | |
MXPA03005743A (es) | Antagonistas muscarinicos. | |
PL358584A1 (en) | Cyclohexylamine derivative as subtype selective nmda receptor antagonists | |
HK1058360A1 (en) | 4-Phenyl-pyridine derivatives as neurokinin-1 receptor antagonists. | |
MXPA03004652A (es) | Derivados de piperidina como antagonistas selectivos de subtipo de n-metil-d-aspartato. | |
HK1051863A1 (en) | Indol-3-yl derivatives. | |
MXPA03006991A (es) | Derivados de piperidina como antagonistas de neurocinina 1. | |
ZA200408281B (en) | Isoquinoline derivatives. | |
AU2001261487A1 (en) | Cyclohexylamine derivatives as subtype selective nmda receptor antagonists | |
HK1042699A1 (en) | N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists. | |
HK1052925A1 (en) | Substituted 1-aminobutan-3-ol derivatives. | |
HK1050889A1 (en) | Substituted aminomehyl-phenyl-cyclohexane derivatives. | |
ZA200205482B (en) | Aminosulfonylbiphenyl derivatives. | |
AU2673201A (en) | Alpha-arylethylpiperazine derivatives as neurokinin antagonists | |
ZA200206150B (en) | Aminomethyl-phenyl-cyclohexanone derivatives. | |
MXPA03002734A (es) | Derivados de 5-amino-1-penten-3-ol sustituidos. | |
NO20024502D0 (no) | 4-okso-1,4-dihydro-3-cinnolinkarboksamider som antivirale midler | |
AU2001268677A1 (en) | Subtype selective melatonergics | |
GB0006860D0 (en) | Antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |